2024-01-22 |
13D/A |
IVVD / Invivyd, Inc. |
Adimab, LLC |
21,687,906 |
19.70 |
-18.74 |
2024-01-12 |
13D/A |
SLDB / Solid Biosciences Inc. |
Perceptive Advisors Llc |
6,925,028 |
18.60 |
97.79 |
2024-01-12 |
13D/A |
SLDB / Solid Biosciences Inc. |
BCLS SB Investco, LP |
2,301,955 |
6.20 |
0.00 |
2024-01-11 |
13D/A |
SLDB / Solid Biosciences Inc. |
Ra Capital Management, L.p. |
4,348,828 |
11.70 |
26.73 |
2024-01-10 |
13D/A |
SLDB / Solid Biosciences Inc. |
BCLS SB Investco, LP |
2,301,955 |
11.40 |
0.00 |
2024-01-09 |
13D/A |
KYMR / Kymera Therapeutics, Inc. |
Biotechnology Value Fund L P |
5,831,171 |
9.99 |
24.26 |
2024-01-09 |
13D/A |
ELUT / Elutia Inc. |
HighCape Capital, L.P. |
9,191,039 |
48.70 |
-28.09 |
2024-01-04 |
13D/A |
IBRX / ImmunityBio, Inc. |
Cambridge Equities, LP |
696,162,179 |
83.50 |
7.07 |
2023-12-29 |
13D/A |
ATHA / Athira Pharma, Inc. |
Perceptive Advisors Llc |
5,458,448 |
14.30 |
13.45 |
2023-12-28 |
13D/A |
FATE / Fate Therapeutics, Inc. |
Redmile Group, LLC |
15,049,839 |
14.90 |
-0.14 |
2023-12-19 |
13D/A |
NKGN / NKGen Biotech, Inc. |
NKMAX Co., Ltd. |
12,917,057 |
53.18 |
|
2023-12-18 |
13D/A |
ACLX / Arcellx, Inc. |
Sr One Capital Management, Llc |
3,146,630 |
6.46 |
-20.27 |
2023-12-15 |
13D/A |
NMRA / Neumora Therapeutics, Inc. |
ARCH Venture Fund XII, L.P. |
31,966,207 |
20.90 |
7.28 |
2023-12-15 |
13D/A |
INAB / IN8bio, Inc. |
BIOS Fund II, LP |
10,416,165 |
23.10 |
|
2023-12-08 |
13D/A |
ABCZF / Abcam Limited |
Hbk Investments L P |
0 |
0.00 |
|
2023-11-29 |
13D/A |
OTLK / Outlook Therapeutics, Inc. |
BioLexis Pte Ltd. |
19,351,493 |
7.40 |
-15.80 |
2023-11-20 |
13D |
MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) |
Biotechnology Value Fund L P |
8,696,205 |
23.90 |
33.94 |
2023-11-20 |
13D/A |
PROK / ProKidney Corp. |
Palihapitiya Chamath |
3,000,000 |
4.50 |
|
2023-11-20 |
13D/A |
ABCZF / Abcam Limited |
Hbk Investments L P |
20,715,000 |
9.00 |
19.95 |
2023-11-20 |
13D/A |
ABCZF / Abcam Limited |
Hbk Investments L P |
20,715,000 |
9.00 |
19.95 |
2023-11-16 |
13D/A |
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) |
Astrazeneca Plc |
16,000,000 |
22.40 |
0.00 |
2023-11-13 |
13D/A |
CGTX / Cognition Therapeutics, Inc. |
BIOS Memory SPV I, LP |
6,006,000 |
19.40 |
8.91 |
2023-11-13 |
13D/A |
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
6,913,153 |
9.70 |
7.56 |
2023-11-09 |
13D/A |
AURA / Aura Biosciences, Inc. |
Matrix Capital Management Company, LP |
6,922,870 |
14.10 |
|
2023-11-09 |
13D |
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock) |
Astrazeneca Plc |
16,000,000 |
22.40 |
|
2023-11-09 |
13D/A |
BDTX / Black Diamond Therapeutics, Inc. |
Versant Venture Capital VI, L.P. |
4,328,883 |
8.40 |
0.00 |
2023-11-09 |
13D/A |
GLUE / Monte Rosa Therapeutics, Inc. |
Versant Venture Capital VI, L.P. |
6,799,115 |
13.70 |
0.00 |
2023-11-09 |
13D/A |
PASG / Passage Bio, Inc. |
Versant Venture Capital VI, L.P. |
4,026,417 |
7.30 |
0.00 |
2023-11-06 |
13D |
ALGS / Aligos Therapeutics, Inc. |
Blatt Lawrence |
3,888,253 |
5.30 |
45.19 |
2023-11-06 |
13D/A |
PROK / ProKidney Corp. |
Palihapitiya Chamath |
11,795,700 |
17.60 |
0.00 |
2023-11-02 |
13D |
PROK / ProKidney Corp. |
Tolerantia, LLC |
89,388,913 |
38.00 |
0.00 |
2023-11-01 |
13D/A |
ABCZF / Abcam Limited |
Milner Jonathan |
14,182,902 |
6.16 |
|
2023-10-30 |
13D/A |
TRML / Tourmaline Bio, Inc. |
Qiming U.S. Healthcare GP II, LLC |
646,770 |
3.20 |
|
2023-10-30 |
13D |
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock) |
Sofinnova Crossover I |
5,264,739 |
8.00 |
|
2023-10-30 |
13D/A |
ZIVO / ZIVO Bioscience, Inc. |
Strome Mezzanine Fund, Lp |
548,905 |
5.30 |
-99.40 |
2023-10-30 |
13D |
ESLA / Estrella Immunopharma, Inc. |
Eureka Therapeutics, Inc. |
25,277,831 |
71.80 |
0.00 |
2023-10-27 |
13D/A |
IOVA / Iovance Biotherapeutics, Inc. |
Quogue Capital LLC |
25,000,000 |
15.84 |
25.00 |
2023-10-27 |
13D/A |
PROK / ProKidney Corp. |
Palihapitiya Chamath |
12,592,500 |
20.40 |
|
2023-10-25 |
13D/A |
ALLO / Allogene Therapeutics, Inc. |
Pfizer Inc |
22,032,040 |
13.14 |
0.00 |
2023-10-23 |
13D/A |
ABCZF / Abcam Limited |
Milner Jonathan |
14,178,402 |
6.16 |
0.03 |
2023-10-19 |
13D/A |
PROK / ProKidney Corp. |
Palihapitiya Chamath |
13,361,473 |
21.70 |
-8.31 |
2023-10-18 |
13D/A |
SRRK / Scholar Rock Holding Corporation |
Samsara BioCapital, L.P. |
7,878,302 |
11.00 |
38.80 |
2023-10-16 |
13D/A |
ABCZF / Abcam Limited |
Milner Jonathan |
14,173,902 |
6.16 |
|
2023-10-16 |
13D |
ABCZF / Abcam Limited |
Hbk Investments L P |
17,270,000 |
7.50 |
|
2023-10-12 |
13D/A |
ABCZF / Abcam Limited |
Milner Jonathan |
14,173,902 |
6.16 |
0.00 |
2023-10-10 |
13D |
NKGN / NKGen Biotech, Inc. |
NKMAX Co., Ltd. |
15,370,633 |
63.40 |
|
2023-10-10 |
13D/A |
ABCZF / Abcam Limited |
Milner Jonathan |
14,173,902 |
6.16 |
|
2023-10-06 |
13D/A |
ELUT / Elutia Inc. |
HighCape Capital, L.P. |
12,781,232 |
68.00 |
128.33 |
2023-10-04 |
13D |
TTNP / Titan Pharmaceuticals, Inc. |
Sire Group Ltd. |
3,001,757 |
16.70 |
|
2023-10-04 |
13D/A |
IMVT / Immunovant, Inc. |
Roivant Sciences Ltd. |
79,815,331 |
55.30 |
8.74 |